Share this article
Share this article
NEW YORK, April 20, 2021 /PRNewswire/ Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced that since November 2020 it has worked with St. John s University, a coeducational Catholic and Vincentian university in New York, to conduct rigorous COVID-19 surveillance testing of student athletes using its pioneering SalivaClear COVID-19 pooled saliva testing platform. The SalivaClear platform consists of three key elements – saliva-based sampling, pooled testing and gold-standard PCR molecular diagnostics – that, when combined, enable frequent, high-quality, high-throughput, low-cost detection of SARS-CoV-2, the virus that causes COVID-19.
Mirimus SalivaClear COVID-19 Pool Testing
St. John s initiated its COVID-19 surveillance program on June 26, 2020 and tests all 300+ student-athletes participating in the university s athletic program, which includes 17 sports, as well as coaches and staff, at least